We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
+$146M
Cap. Flow %
3.08%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Avg Time Held Equity + Options
3.8 quarters
Top 10 Avg Time Held Equity + Options
1.1 quarters
Top 20 Avg Time Held Equity + Options
1.1 quarters
Avg Time Held Equity only
3.9 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.68%
3 Financials 11.99%
4 Miscellaneous 10.5%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WCC icon
426
WESCO International
WCC
$17.6B
$507K 0.01%
+2,830
New +$413K
2023 Q2
0 quarters
ADBE icon
427
Adobe
ADBE
$92.5B
$505K 0.01%
1,033
-8,967
-90% -$3.61M
2023 Q1
1 quarter
CTRE icon
428
CareTrust REIT
CTRE
$8.65B
$502K 0.01%
+25,270
New +$494K
2023 Q2
0 quarters
ASAN icon
429
Asana
ASAN
$2.29B
$474K 0.01%
21,510
-203,490
-90% -$4.08M
2023 Q1
1 quarter
PEN icon
430
Penumbra
PEN
$12.6B
$471K 0.01%
1,369
-1,073
-44% -$329K
2022 Q1
5 quarters
UBX icon
431
DELISTED
Unity Biotechnology
UBX
$457K 0.01%
179,080
-33,960
-16% -$89.7K
2022 Q3
3 quarters
SPY icon
432
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$456K 0.01%
449,000
+54,000
+14% +$22.7M
2019 Q4
14 quarters
CPRI icon
433
PUT
Capri Holdings
CPRI
$1.73B
$452K 0.01%
18,200
– –
2021 Q2
8 quarters
F icon
434
PUT
Ford
F
$47.7B
$450K 0.01%
740,900
-30,300
-4% -$383K
2022 Q2
4 quarters
CTMX icon
435
CytomX Therapeutics
CTMX
$527M
$447K 0.01%
259,965
+12,808
+5% +$21.3K
2022 Q4
2 quarters
CYPH icon
436
Cypherpunk Technologies Inc
CYPH
$313M
$436K 0.01%
139,434
+34,565
+33% +$174K
2023 Q1
1 quarter
OVID icon
437
Ovid Therapeutics
OVID
$473M
$426K 0.01%
+130,000
New +$441K
2023 Q2
0 quarters
SPLK icon
438
DELISTED
Splunk Inc
SPLK
$424K 0.01%
+4,000
New +$380K
2023 Q2
0 quarters
GPCR icon
439
Structure Therapeutics
GPCR
$1.73B
$424K 0.01%
10,193
-11,857
-54% -$332K
2023 Q1
1 quarter
M icon
440
PUT
Macy's
M
$6.02B
$419K 0.01%
112,500
– –
2021 Q2
8 quarters
LCID icon
441
Lucid Motors
LCID
$1.36B
$413K 0.01%
+6,000
New +$428K
2023 Q2
0 quarters
ESPR icon
442
DELISTED
Esperion Therapeutics
ESPR
$413K 0.01%
296,947
+90,688
+44% +$127K
2022 Q3
3 quarters
ABOS icon
443
Acumen Pharmaceuticals
ABOS
$146M
$383K 0.01%
79,538
+18,180
+30% +$87K
2022 Q4
2 quarters
SAVE icon
444
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$382K 0.01%
250,000
+150,000
+150% +$2.46M
2022 Q3
3 quarters
ORTX
445
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$369K 0.01%
71,010
+3,498
+5% +$17.8K
2022 Q1
5 quarters
SPT icon
446
Sprout Social
SPT
$671M
$346K 0.01%
7,500
-22,500
-75% -$1.07M
2023 Q1
1 quarter
QURE icon
447
PUT
uniQure
QURE
$1.5B
$338K 0.01%
+55,000
New +$1.04M
2023 Q2
0 quarters
RNG icon
448
RingCentral
RNG
$6.51B
$332K 0.01%
10,155
-22,500
-69% -$691K
2023 Q1
1 quarter
PRQR icon
449
ProQR Therapeutics
PRQR
$236M
$307K 0.01%
189,328
+9,328
+5% +$18.2K
2023 Q1
1 quarter
PLTR icon
450
Palantir
PLTR
$498B
$303K 0.01%
+19,773
New +$225K
2023 Q2
0 quarters

Similar funds

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor deployed $146M of net new capital in Q2 2023, opening 128 new positions and adding to 150 existing holdings. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Tower Semiconductor, an estimated $50.8M trimmed.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.